Prognostic value of inflammation-based prognostic index in patients with nasopharyngeal carcinoma: a propensity score matching study

被引:27
|
作者
Oei, Ronald Wihal [1 ,2 ]
Ye, Lulu [1 ,2 ]
Kong, Fangfang [1 ,2 ]
Du, Chengrun [1 ,2 ]
Zhai, Ruiping [1 ,2 ]
Xu, Tingting [1 ,2 ]
Shen, Chunying [1 ,2 ]
Wang, Xiaoshen [1 ,2 ]
He, Xiayun [1 ,2 ]
Kong, Lin [1 ,2 ]
Hu, Chaosu [1 ,2 ]
Ying, Hongmei [1 ,2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, 270 Dongan Rd, Shanghai 200032, Peoples R China
[2] Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
来源
关键词
prognostic nutritional index; systemic immune-inflammation index; nasopharyngeal carcinoma; intensity-modulated radiotherapy; prognostic factor; survival; INTENSITY-MODULATED RADIOTHERAPY; ANTIINFLAMMATORY DRUG-USE; NUTRITIONAL INDEX; CURATIVE RESECTION; CANCER; SURVIVAL; PREDICTS; METASTASIS; CACHEXIA; OUTCOMES;
D O I
10.2147/CMAR.S171239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this article is to investigate the significance of pretreatment prognostic nutritional index (PNI), systemic immune-inflammation index (SII), and their combination in nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT). Materials and methods: A total of 585 patients were included. PNI and SII were calculated within 2 weeks prior to treatment. The optimal cutoff points were determined based on receiver operating characteristics curve analysis. The correlation between variables was analyzed. Kaplan-Meier method and Cox proportional hazards model were performed to evaluate the impact of both indices on overall survival (OS), progression-free survival (PFS) and distant metastasis-free survival (DMFS). Further propensity score matching (PSM) was carried out to minimize the effects of confounders. Results: The optimal cutoff point of 53.0 for PNI and 527.20 for SII were selected. Pearson correlation coefficient showed an inverse correlation between PNI and SII (r = -0.232, P < 0.001). Multivariate analysis demonstrated that pretreatment PNI was an independent prognostic factor for OS (P = 0.047) and DMFS (P = 0.002) while pretreatment SII was an independent prognostic factor for OS (P = 0.003), PFS (P = 0.002), and DMFS (P = 0.002). After PSM, both parameters remained as independent prognosticators of survival. Additional prognostic value was observed in the combined use of PNI and SII. Conclusion: Pretreatment PNI and SII are promising indicators of survival in NPC patients undergoing IMRT. They can be utilized to refine current TNM staging system in predicting prognosis and developing an individualized treatment in these patients.
引用
收藏
页码:2785 / 2797
页数:13
相关论文
共 50 条
  • [31] The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: A literature review
    Gao, Yongyin
    Huang, Dingzhi
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) : 799 - 804
  • [32] Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer
    Sharma, Rohini
    Hook, Jane
    Kumar, Munish
    Gabra, Hani
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (02) : 251 - 256
  • [33] Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer
    Glen, Paul
    Jamieson, Nigel B.
    McMillan, Donald C.
    Carter, Ross
    Imrie, Clem W.
    McKay, Colin J.
    PANCREATOLOGY, 2006, 6 (05) : 450 - 453
  • [34] The Inflammation-Based Glasgow Prognostic Score as a Prognostic Factor in Patients with Intensive Cardiovascular Care Unit
    Altay, Servet
    Gurdogan, Muhammet
    Keskin, Muhammed
    Kardas, Fatih
    Cakir, Burcu
    MEDICINA-LITHUANIA, 2019, 55 (05):
  • [35] Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer
    Ramsey, Sara
    Lamb, Gavin W. A.
    Aitchison, Michael
    Graham, John
    McMillan, Donald G.
    CANCER, 2007, 109 (02) : 205 - 212
  • [36] The systemic inflammation-based Glasgow Prognostic Score as a prognostic factor in patients with acute heart failure
    Namiuchi, Shigeto
    Sugie, Tadashi
    Saji, Kenya
    Takii, Toru
    Suda, Akira
    Kato, Atsushi
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2015, 16 (06) : 409 - 415
  • [37] Inflammation-based prognostic score in living donor liver transplantation for hepatocellular carcinoma
    Harimoto, Norifumi
    Yoshizumi, Tomoharu
    Itoh, Shinji
    Ikegami, Toru
    Uchiyama, Hideaki
    Ikeda, Tetsuo
    Soejima, Yuji
    Maehara, Yoshihiko
    TRANSPLANTATION, 2016, 100 (07) : S148 - S148
  • [38] Optimization of the systemic inflammation-based Glasgow Prognostic Score
    Proctor, Michael J.
    Horgan, Paul G.
    Talwar, Dinesh
    Fletcher, Colin D.
    Morrison, David S.
    McMillan, Donald C.
    CANCER, 2013, 119 (12) : 2325 - 2332
  • [39] The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer
    Hefler-Frischmuth, Katrin
    Seebacher, Veronika
    Polterauer, Stephan
    Tempfer, Clemens
    Reinthaller, Alexander
    Hefler, Lukas
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 149 (01) : 102 - 105
  • [40] Verification of inflammation-based prognostic marker as a prognostic indicator in hepatocellular carcinoma
    Yamamoto, Masateru
    Kobayashi, Tsuyoshi
    Kuroda, Shintaro
    Hamaoka, Michinori
    Okimoto, Sho
    Honmyo, Naruhiko
    Yamaguchi, Megumi
    Ohdan, Hideki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2019, 3 (06): : 667 - 675